Cantor Fitzgerald raised their FY2025 earnings per share (EPS) estimates for Jasper Therapeutics in a research note issued on ...

Carmell announced a comprehensive corporate rebranding initiative aimed at better aligning the Company’s market and investor facing image with ...

Design has initiated dosing in a Phase 1 clinical trial in healthy volunteers in Australia to evaluate the safety and ...

REDWOOD CITY, Calif. - Jasper Therapeutics, Inc. (NASDAQ:JSPR), a biotech company specializing in antibody therapies, announced plans to initiate a Phase 1b/2a clinical trial for ...

This page features the latest news about the Jasper Therapeutics stock. Jasper Therapeutics Falls 40% Following Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria Jasper ...

The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...

The federal and Alberta governments are ushering in new support for Jasper as the mountain town continues to rebuild from last summer’s devastating wildfires. The federal government says $2 ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Roche Holding AG Akt 0.25% CHF244.62B ...